REIMBURSEMENT: Class III DME Could Lose Out On Payment Update

Why This Topic Matters

Changes to DME payment updates can affect Medicare reimbursement policy for medical device suppliers and manufacturers. Understanding the report is important for readers following federal payment methodology, class-based device regulation, and the role of HHS, Congress, and GAO in shaping reimbursement updates.

Article Sections

1. GAO recommendation on DME payment updates

   Introduces the report’s concern with annual payment updates for class III durable medical equipment and the policy question around whether updates should be uniform across device classes.

2. Class III DME spending trends and Medicare coverage

   Summarizes the growth in Medicare spending and the categories of class III devices discussed in the report. It also places the issue in the context of Medicare coverage and the federal device classification system.

3. Medicare Modernization Act and payment update framework

   Describes the statutory backdrop for payment updates in the relevant years and the roles of Congress and HHS in setting rates.

4. Pre-marketing costs and fee schedule considerations

   Reviews the report’s examination of pre-marketing costs, device regulation, and the relationship between retail pricing and the DME fee schedule.

5. Industry reaction

   Notes the response from a medical technology trade group regarding the report’s conclusions and the requested payment update guidance.